Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of Concurrent Administration of Live, Attenuated SA 14-14-2 Japanese Encephalitis Vaccine and Measles-Mumps-Rubella Vaccine in Infants 9-12 Months of Age in the Philippines

NCT02880865 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT02880865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02880865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of Concurrent Administration of Live, Attenuated SA 14-14-2 Japanese Encephalitis Vaccine and Measles-Mumps-Rubella Vaccine in Infants 9-12 Months of Age in the Philippines
Lead sponsor
PATH
Phase
Phase 4
Overall status
Completed
Start date
October 13, 2016
Completion date
July 11, 2017
Enrollment
628 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

encephalitis, japanese, measles, mumps, rubella